image
Healthcare - Biotechnology - NASDAQ - US
$ 3.94
2.07 %
$ 278 M
Market Cap
-2.42
P/E
BALANCE SHEET
376 M ASSETS
-12.62%
130 M LIABILITIES
-7.96%
246 M EQUITY
-14.91%
BALANCE SHEET DECOMPOSITION
Balance Sheet C4 Therapeutics, Inc.
image
Current Assets 271 M
Cash & Short-Term Investments 254 M
Receivables 11.8 M
Other Current Assets 5.71 M
Non-Current Assets 105 M
Long-Term Investments 28 M
PP&E 71.1 M
Other Non-Current Assets 6.17 M
Current Liabilities 42.8 M
Accounts Payable 1.45 M
Short-Term Debt 5.22 M
Other Current Liabilities 36.1 M
Non-Current Liabilities 87.6 M
Long-Term Debt 65.8 M
Other Non-Current Liabilities 21.8 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018
ASSETS
Cash & Cash Equivalents 126.6 29.8 76.1 181.7 90.5 36.3
Short Term Investments 127.1 246.4 233.2 190.0 0 0
Receivables 11.8 1.5 5.7 4.5 4.6 86.4
Inventory 0 (61.0) 0 0 1 1
Other Current Assets 5.7 9.9 21.4 9.7 3.2 0.8
Total Current Assets 271.2 287.6 325.7 381.0 96.8 123.5
PP&E 71.1 77.5 35.1 16.6 18.9 20.4
Intangible Assets 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0
Long Term Investments 28.0 61.0 142.2 2.6 2.6 2.6
Other Long Term Assets 6.2 4.8 3.8 0 0 0
Other Assets 0 0 0 0 0 0
Total Assets 376.5 430.8 506.8 400.1 118.3 146.5
LIABILITIES
Accounts Payable 1.4 1.2 4.5 5.7 5.4 1.2
Short Term Debt 5.2 11.7 2.7 2.1 0.9 0.7
Other Current Liabilities 20.6 15.1 12.3 8.5 27.4 3.0
Total Current Liabilities 42.8 44.5 51.2 43.9 33.6 23.9
Long Term Debt 65.8 80.2 72.3 33.7 12.9 13.7
Deferred Tax Income 0 9.2 10.8 10.1 0 (13.7)
Other Liabilities 0 0 (30.8) (11.8) 111.0 111.0
Total Liabilities 130.3 141.6 117.2 119.3 230.2 226.2
EQUITY
Common Stock 6 K 5 K 5 K 4 K 1 K 1 K
Retained Earnings (528.4) (395.9) (267.7) (183.8) (117.5) (83.4)
Other Accumulative Comprehensive Income/Loss (0.1) (4.1) (0.8) 13 K 1 K (2.5)
Total Equity 246.1 289.2 389.6 280.8 (112.0) (79.8)
Total Liabilities and Equity 376.5 430.8 506.8 400.1 118.3 146.5
SHARES OUTSTANDING
Common Shares Outstanding 49.6 48.9 46.0 43.1 43.0 14.8